25 XP   0   0   10

Genovate Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse Genovate Biotechnology Co Ltd together

PenkeI guess you are interested in Genovate Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genovate Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genovate Biotechnology Co Ltd

I send you an email if I find something interesting about Genovate Biotechnology Co Ltd.

Quick analysis of Genovate Biotechnology Co Ltd (30 sec.)










What can you expect buying and holding a share of Genovate Biotechnology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
66.7%

What is your share worth?

Current worth
NT$13.43
Expected worth in 1 year
NT$13.96
How sure are you?
71.4%

+ What do you gain per year?

Total Gains per Share
NT$0.53
Return On Investment
2.2%

For what price can you sell your share?

Current Price per Share
NT$24.05
Expected price per share
NT$21.08 - NT$24.70
How sure are you?
50%

1. Valuation of Genovate Biotechnology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$24.05

Intrinsic Value Per Share

NT$-1.86 - NT$-2.23

Total Value Per Share

NT$11.57 - NT$11.20

2. Growth of Genovate Biotechnology Co Ltd (5 min.)




Is Genovate Biotechnology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$45m$42.9m$2.5m5.6%

How much money is Genovate Biotechnology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$225.1k-$94.5k$319.7k142.0%
Net Profit Margin5.0%-2.9%--

How much money comes from the company's main activities?

3. Financial Health of Genovate Biotechnology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#483 / 1010

Most Revenue
#370 / 1010

Most Profit
#160 / 1010

Most Efficient
#137 / 1010

What can you expect buying and holding a share of Genovate Biotechnology Co Ltd? (5 min.)

Welcome investor! Genovate Biotechnology Co Ltd's management wants to use your money to grow the business. In return you get a share of Genovate Biotechnology Co Ltd.

What can you expect buying and holding a share of Genovate Biotechnology Co Ltd?

First you should know what it really means to hold a share of Genovate Biotechnology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Genovate Biotechnology Co Ltd is NT$24.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genovate Biotechnology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genovate Biotechnology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$13.43. Based on the TTM, the Book Value Change Per Share is NT$0.13 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genovate Biotechnology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.030.1%
Usd Price Per Share0.82-0.84-0.83-0.85-0.85-
Price to Earnings Ratio-50.79-26.81-78.52-35.31-261.49-
Price-to-Total Gains Ratio1,784.91-368.00--213.72-61.00-58.18-
Price to Book Ratio1.98-2.02-2.11-2.13-2.12-
Price-to-Total Gains Ratio1,784.91-368.00--213.72-61.00-58.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.738335
Number of shares1354
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (1354 shares)5.518.11
Gains per Year (1354 shares)22.0232.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10221240-722
20443479-1454
306656119-2286
408878159-29118
50110100198-36150
60132122238-43182
70154144277-50214
80176166317-58246
90198188357-65278
100220210396-72310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%15.06.00.071.4%15.06.00.071.4%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%9.012.00.042.9%9.012.00.042.9%
Dividend per Share0.00.04.00.0%7.00.05.058.3%13.00.07.065.0%14.00.07.066.7%14.00.07.066.7%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%14.06.00.070.0%15.06.00.071.4%15.06.00.071.4%

Fundamentals of Genovate Biotechnology Co Ltd

About Genovate Biotechnology Co Ltd

Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company in Taiwan. It offers central nervous system drugs, cardiovascular drugs, musculoskeletal drugs, immune preparation drugs, anti-infective agents, anticancer drugs, anti-viral drugs, respiratory drugs, genitourinary drugs, and gastrointestinal drugs. The company manufactures active pharmaceutical ingredients, intermediates, controlled release medicine, and cosmetic products. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.

Fundamental data was last updated by Penke on 2024-04-16 21:57:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Genovate Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genovate Biotechnology Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -12.0% means that NT$-0.12 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genovate Biotechnology Co Ltd:

  • The MRQ is -12.0%. The company is making a huge loss. -2
  • The TTM is 5.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM5.0%-17.0%
TTM5.0%YOY-2.9%+8.0%
TTM5.0%5Y3.2%+1.8%
5Y3.2%10Y3.0%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%-207.2%+195.2%
TTM5.0%-216.8%+221.8%
YOY-2.9%-282.3%+279.4%
5Y3.2%-436.8%+440.0%
10Y3.0%-597.3%+600.3%
1.1.2. Return on Assets

Shows how efficient Genovate Biotechnology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • -0.9% Return on Assets means that Genovate Biotechnology Co Ltd generated NT$-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genovate Biotechnology Co Ltd:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM0.4%-1.3%
TTM0.4%YOY-0.2%+0.6%
TTM0.4%5Y0.3%+0.2%
5Y0.3%10Y0.3%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-13.3%+12.4%
TTM0.4%-12.8%+13.2%
YOY-0.2%-11.6%+11.4%
5Y0.3%-13.8%+14.1%
10Y0.3%-15.6%+15.9%
1.1.3. Return on Equity

Shows how efficient Genovate Biotechnology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • -1.0% Return on Equity means Genovate Biotechnology Co Ltd generated NT$-0.01 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genovate Biotechnology Co Ltd:

  • The MRQ is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM0.5%-1.5%
TTM0.5%YOY-0.2%+0.7%
TTM0.5%5Y0.3%+0.2%
5Y0.3%10Y0.3%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.0%-16.9%+15.9%
TTM0.5%-16.1%+16.6%
YOY-0.2%-14.9%+14.7%
5Y0.3%-19.3%+19.6%
10Y0.3%-20.1%+20.4%

1.2. Operating Efficiency of Genovate Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genovate Biotechnology Co Ltd is operating .

  • Measures how much profit Genovate Biotechnology Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.6%-2.6%
TTM2.6%YOY0.0%+2.6%
TTM2.6%5Y5.3%-2.8%
5Y5.3%10Y5.0%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM2.6%-238.5%+241.1%
YOY0.0%-288.4%+288.4%
5Y5.3%-486.2%+491.5%
10Y5.0%-628.4%+633.4%
1.2.2. Operating Ratio

Measures how efficient Genovate Biotechnology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are NT$1.78 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 1.780. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.557. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.780TTM1.557+0.222
TTM1.557YOY1.680-0.123
TTM1.5575Y1.584-0.026
5Y1.58410Y1.582+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7803.235-1.455
TTM1.5573.310-1.753
YOY1.6803.838-2.158
5Y1.5845.679-4.095
10Y1.5827.823-6.241

1.3. Liquidity of Genovate Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genovate Biotechnology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.56 means the company has NT$6.56 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 6.556. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.977. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.556TTM5.977+0.578
TTM5.977YOY5.426+0.551
TTM5.9775Y5.442+0.535
5Y5.44210Y5.426+0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5563.863+2.693
TTM5.9774.169+1.808
YOY5.4265.337+0.089
5Y5.4426.122-0.680
10Y5.4266.434-1.008
1.3.2. Quick Ratio

Measures if Genovate Biotechnology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 3.67 means the company can pay off NT$3.67 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 3.667. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.397. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.667TTM3.397+0.269
TTM3.397YOY2.872+0.525
TTM3.3975Y2.692+0.705
5Y2.69210Y2.676+0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6673.504+0.163
TTM3.3973.991-0.594
YOY2.8725.371-2.499
5Y2.6926.088-3.396
10Y2.6766.395-3.719

1.4. Solvency of Genovate Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genovate Biotechnology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genovate Biotechnology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Genovate Biotechnology Co Ltd assets are financed with 8.2% credit (debt) and the remaining percentage (100% - 8.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 0.082. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.089. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.089-0.006
TTM0.089YOY0.102-0.014
TTM0.0895Y0.099-0.011
5Y0.09910Y0.099+0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.339-0.257
TTM0.0890.337-0.248
YOY0.1020.271-0.169
5Y0.0990.368-0.269
10Y0.0990.388-0.289
1.4.2. Debt to Equity Ratio

Measures if Genovate Biotechnology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.0% means that company has NT$0.09 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genovate Biotechnology Co Ltd:

  • The MRQ is 0.090. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.097. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.090TTM0.097-0.008
TTM0.097YOY0.114-0.017
TTM0.0975Y0.111-0.014
5Y0.11110Y0.111+0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0900.392-0.302
TTM0.0970.403-0.306
YOY0.1140.335-0.221
5Y0.1110.427-0.316
10Y0.1110.461-0.350

2. Market Valuation of Genovate Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Genovate Biotechnology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Genovate Biotechnology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -50.79 means the investor is paying NT$-50.79 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genovate Biotechnology Co Ltd:

  • The EOD is -45.923. Based on the earnings, the company is expensive. -2
  • The MRQ is -50.793. Based on the earnings, the company is expensive. -2
  • The TTM is 26.811. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-45.923MRQ-50.793+4.869
MRQ-50.793TTM26.811-77.604
TTM26.811YOY78.521-51.710
TTM26.8115Y35.307-8.496
5Y35.30710Y261.493-226.186
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-45.923-2.300-43.623
MRQ-50.793-2.656-48.137
TTM26.811-2.718+29.529
YOY78.521-4.145+82.666
5Y35.307-6.258+41.565
10Y261.493-6.315+267.808
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genovate Biotechnology Co Ltd:

  • The EOD is 66.995. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 74.098. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 17.964. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD66.995MRQ74.098-7.103
MRQ74.098TTM17.964+56.135
TTM17.964YOY32.151-14.187
TTM17.9645Y2.572+15.392
5Y2.57210Y-5.600+8.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD66.995-2.974+69.969
MRQ74.098-3.306+77.404
TTM17.964-3.508+21.472
YOY32.151-5.613+37.764
5Y2.572-8.378+10.950
10Y-5.600-8.873+3.273
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genovate Biotechnology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.98 means the investor is paying NT$1.98 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Genovate Biotechnology Co Ltd:

  • The EOD is 1.791. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.981. Based on the equity, the company is underpriced. +1
  • The TTM is 2.020. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.791MRQ1.981-0.190
MRQ1.981TTM2.020-0.040
TTM2.020YOY2.107-0.086
TTM2.0205Y2.131-0.110
5Y2.13110Y2.124+0.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7911.914-0.123
MRQ1.9812.116-0.135
TTM2.0202.097-0.077
YOY2.1072.881-0.774
5Y2.1313.550-1.419
10Y2.1243.936-1.812
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Genovate Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0150.132-89%0.073-80%-0.043+391%0.639-98%
Book Value Per Share--13.42913.538-1%12.783+5%13.020+3%13.081+3%
Current Ratio--6.5565.977+10%5.426+21%5.442+20%5.426+21%
Debt To Asset Ratio--0.0820.089-7%0.102-19%0.099-17%0.099-17%
Debt To Equity Ratio--0.0900.097-8%0.114-21%0.111-19%0.111-19%
Dividend Per Share----0%0.259-100%0.238-100%0.240-100%
Eps---0.1310.067-295%0.032-512%0.053-346%0.051-358%
Free Cash Flow Per Share--0.0900.118-24%-0.051+157%0.032+183%0.028+218%
Free Cash Flow To Equity Per Share--0.0900.116-23%-0.140+256%-0.043+148%-0.043+148%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.227--------
Intrinsic Value_10Y_min---1.855--------
Intrinsic Value_1Y_max---0.049--------
Intrinsic Value_1Y_min---0.048--------
Intrinsic Value_3Y_max---0.280--------
Intrinsic Value_3Y_min---0.265--------
Intrinsic Value_5Y_max---0.671--------
Intrinsic Value_5Y_min---0.612--------
Market Cap2630492800.000-11%2909401600.0002991433600.000-3%2947683200.000-1%3026981893.760-4%3030498019.657-4%
Net Profit Margin---0.1200.050-340%-0.029-75%0.032-478%0.030-496%
Operating Margin---0.026-100%0.0000%0.053-100%0.050-100%
Operating Ratio--1.7801.557+14%1.680+6%1.584+12%1.582+12%
Pb Ratio1.791-11%1.9812.020-2%2.107-6%2.131-7%2.124-7%
Pe Ratio-45.923+10%-50.79326.811-289%78.521-165%35.307-244%261.493-119%
Price Per Share24.050-11%26.60027.350-3%26.950-1%27.675-4%27.707-4%
Price To Free Cash Flow Ratio66.995-11%74.09817.964+312%32.151+130%2.572+2781%-5.600+108%
Price To Total Gains Ratio1613.799-11%1784.909367.995+385%-213.725+112%60.996+2826%58.184+2968%
Quick Ratio--3.6673.397+8%2.872+28%2.692+36%2.676+37%
Return On Assets---0.0090.004-301%-0.002-78%0.003-418%0.003-434%
Return On Equity---0.0100.005-298%-0.002-77%0.003-411%0.003-426%
Total Gains Per Share--0.0150.132-89%0.332-96%0.195-92%0.880-98%
Usd Book Value--45091239.00045457628.150-1%42922322.375+5%43718915.230+3%43922728.290+3%
Usd Book Value Change Per Share--0.0000.004-89%0.002-80%-0.001+391%0.020-98%
Usd Book Value Per Share--0.4120.416-1%0.392+5%0.400+3%0.402+3%
Usd Dividend Per Share----0%0.008-100%0.007-100%0.007-100%
Usd Eps---0.0040.002-295%0.001-512%0.002-346%0.002-358%
Usd Free Cash Flow--301351.200394794.325-24%-172718.200+157%106568.910+183%94789.905+218%
Usd Free Cash Flow Per Share--0.0030.004-24%-0.002+157%0.001+183%0.001+218%
Usd Free Cash Flow To Equity Per Share--0.0030.004-23%-0.004+256%-0.001+148%-0.001+148%
Usd Market Cap80756128.960-11%89318629.12091837011.520-3%90493874.240-1%92928344.138-4%93036289.203-4%
Usd Price Per Share0.738-11%0.8170.840-3%0.827-1%0.850-4%0.851-4%
Usd Profit---439624.000225138.450-295%-94579.025-78%138409.415-418%132055.319-433%
Usd Revenue--3667022.9004056329.600-10%3367475.325+9%3591906.140+2%3581567.257+2%
Usd Total Gains Per Share--0.0000.004-89%0.010-96%0.006-92%0.027-98%
 EOD+3 -5MRQTTM+8 -25YOY+17 -175Y+19 -1610Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Genovate Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-45.923
Price to Book Ratio (EOD)Between0-11.791
Net Profit Margin (MRQ)Greater than0-0.120
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.667
Current Ratio (MRQ)Greater than16.556
Debt to Asset Ratio (MRQ)Less than10.082
Debt to Equity Ratio (MRQ)Less than10.090
Return on Equity (MRQ)Greater than0.15-0.010
Return on Assets (MRQ)Greater than0.05-0.009
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Genovate Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.385
Ma 20Greater thanMa 5024.593
Ma 50Greater thanMa 10025.048
Ma 100Greater thanMa 20025.745
OpenGreater thanClose24.300
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets1,600,456
Total Liabilities131,686
Total Stockholder Equity1,468,770
 As reported
Total Liabilities 131,686
Total Stockholder Equity+ 1,468,770
Total Assets = 1,600,456

Assets

Total Assets1,600,456
Total Current Assets771,772
Long-term Assets828,684
Total Current Assets
Cash And Cash Equivalents 180,032
Short-term Investments 359,272
Net Receivables 72,390
Inventory 139,642
Total Current Assets  (as reported)771,772
Total Current Assets  (calculated)751,336
+/- 20,436
Long-term Assets
Property Plant Equipment 392,121
Long-term Assets Other 12,961
Long-term Assets  (as reported)828,684
Long-term Assets  (calculated)405,082
+/- 423,602

Liabilities & Shareholders' Equity

Total Current Liabilities117,726
Long-term Liabilities13,960
Total Stockholder Equity1,468,770
Total Current Liabilities
Accounts payable 32,867
Other Current Liabilities 26,213
Total Current Liabilities  (as reported)117,726
Total Current Liabilities  (calculated)59,080
+/- 58,646
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt683
Long-term Liabilities Other 13,942
Long-term Liabilities  (as reported)13,960
Long-term Liabilities  (calculated)14,625
+/- 665
Total Stockholder Equity
Retained Earnings 13,498
Total Stockholder Equity (as reported)1,468,770
Total Stockholder Equity (calculated)13,498
+/- 1,455,272
Other
Capital Stock1,093,758
Common Stock Shares Outstanding 109,376
Net Invested Capital 1,468,770
Net Working Capital 654,046
Property Plant and Equipment Gross 392,121



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
1,735,808
1,690,461
1,692,213
1,629,156
1,572,910
1,453,558
1,556,344
1,520,225
1,570,828
1,577,695
1,567,724
1,543,250
1,515,512
1,556,014
1,596,251
1,512,945
1,564,428
1,653,765
1,624,966
1,619,278
1,600,456
1,600,4561,619,2781,624,9661,653,7651,564,4281,512,9451,596,2511,556,0141,515,5121,543,2501,567,7241,577,6951,570,8281,520,2251,556,3441,453,5581,572,9101,629,1561,692,2131,690,4611,735,808
   > Total Current Assets 
683,142
685,859
734,164
691,495
683,997
706,871
706,970
672,737
631,646
645,179
639,268
637,582
634,930
741,011
735,202
703,771
781,877
774,994
779,474
802,021
771,772
771,772802,021779,474774,994781,877703,771735,202741,011634,930637,582639,268645,179631,646672,737706,970706,871683,997691,495734,164685,859683,142
       Cash And Cash Equivalents 
219,904
224,495
274,631
236,985
200,669
240,798
219,631
249,386
223,213
207,378
194,102
217,202
198,441
209,357
174,057
177,280
194,165
195,178
182,596
181,448
180,032
180,032181,448182,596195,178194,165177,280174,057209,357198,441217,202194,102207,378223,213249,386219,631240,798200,669236,985274,631224,495219,904
       Short-term Investments 
232,100
232,100
232,100
222,100
257,100
237,100
252,980
192,980
197,980
197,980
197,980
177,980
190,980
292,987
317,999
286,019
302,880
332,866
342,973
359,060
359,272
359,272359,060342,973332,866302,880286,019317,999292,987190,980177,980197,980197,980197,980192,980252,980237,100257,100222,100232,100232,100232,100
       Net Receivables 
83,344
98,365
90,486
93,165
82,620
100,504
100,573
94,960
69,327
78,225
90,261
96,549
95,162
91,086
94,870
96,387
85,501
104,970
111,333
95,595
72,390
72,39095,595111,333104,97085,50196,38794,87091,08695,16296,54990,26178,22569,32794,960100,573100,50482,62093,16590,48698,36583,344
       Inventory 
122,381
107,643
113,741
115,530
135,624
117,607
122,023
130,879
139,639
158,423
146,405
139,954
139,943
138,296
140,358
133,233
145,861
134,587
132,320
141,039
139,642
139,642141,039132,320134,587145,861133,233140,358138,296139,943139,954146,405158,423139,639130,879122,023117,607135,624115,530113,741107,643122,381
       Other Current Assets 
59
59
59
61
4
4
20
16
20
20
20
20
22
22
224
224
0
286
286
0
0
00286286022422422222020202016204461595959
   > Long-term Assets 
0
1,004,602
958,049
937,661
888,913
746,687
849,374
847,488
939,182
932,516
928,456
905,668
880,582
815,003
861,049
809,174
782,551
878,771
845,492
817,257
828,684
828,684817,257845,492878,771782,551809,174861,049815,003880,582905,668928,456932,516939,182847,488849,374746,687888,913937,661958,0491,004,6020
       Property Plant Equipment 
441,156
438,471
441,121
438,947
436,950
437,295
438,819
433,963
435,033
426,270
419,448
414,699
409,597
409,882
412,933
407,478
403,288
398,988
396,099
396,368
392,121
392,121396,368396,099398,988403,288407,478412,933409,882409,597414,699419,448426,270435,033433,963438,819437,295436,950438,947441,121438,471441,156
       Long Term Investments 
583,081
536,517
488,455
469,060
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000469,060488,455536,517583,081
       Intangible Assets 
2,306
3,068
3,019
2,707
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,7073,0193,0682,306
       Long-term Assets Other 
0
4,884
3,792
5,285
5,792
3,180
6,069
5,368
3,381
4,155
3,908
6,113
8,312
6,981
5,259
5,209
5,209
7,982
10,036
12,505
12,961
12,96112,50510,0367,9825,2095,2095,2596,9818,3126,1133,9084,1553,3815,3686,0693,1805,7925,2853,7924,8840
> Total Liabilities 
172,323
135,023
173,160
132,447
164,684
211,209
186,831
129,806
144,867
182,713
165,343
161,072
136,646
180,226
173,241
130,085
153,601
150,491
141,332
152,138
131,686
131,686152,138141,332150,491153,601130,085173,241180,226136,646161,072165,343182,713144,867129,806186,831211,209164,684132,447173,160135,023172,323
   > Total Current Liabilities 
133,824
102,248
140,679
100,027
130,653
184,052
158,363
101,600
116,408
160,394
143,379
139,125
110,613
161,306
153,149
110,315
131,841
138,262
129,343
140,151
117,726
117,726140,151129,343138,262131,841110,315153,149161,306110,613139,125143,379160,394116,408101,600158,363184,052130,653100,027140,679102,248133,824
       Short-term Debt 
0
159
150
5,500
153
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001535,5001501590
       Short Long Term Debt 
0
159
150
5,500
153
5,656
112
81
13,567
5,457
131
105
119
119
105
105
111
101
86
62
0
062861011111051051191191051315,45713,567811125,6561535,5001501590
       Accounts payable 
40,882
28,682
42,860
27,523
49,419
34,728
38,946
35,032
36,797
48,532
38,174
28,692
35,000
40,986
36,510
32,984
45,798
34,838
34,023
40,654
32,867
32,86740,65434,02334,83845,79832,98436,51040,98635,00028,69238,17448,53236,79735,03238,94634,72849,41927,52342,86028,68240,882
       Other Current Liabilities 
59,138
14,363
14,290
16,094
47,472
117,744
92,366
37,531
47,176
82,004
82,926
86,075
45,476
85,664
86,338
46,758
49,125
70,358
68,342
39,398
26,213
26,21339,39868,34270,35849,12546,75886,33885,66445,47686,07582,92682,00447,17637,53192,366117,74447,47216,09414,29014,36359,138
   > Long-term Liabilities 
0
32,775
32,481
32,420
34,031
27,157
28,468
28,206
28,459
22,319
21,964
21,947
26,033
18,920
20,092
19,770
21,760
12,229
11,989
11,987
13,960
13,96011,98711,98912,22921,76019,77020,09218,92026,03321,94721,96422,31928,45928,20628,46827,15734,03132,42032,48132,7750
       Capital Lease Obligations Min Short Term Debt
0
1,778
1,417
-4,238
789
608
2,600
2,338
2,063
1,776
1,476
1,162
833
490
2,366
2,110
1,838
1,651
1,346
1,024
683
6831,0241,3461,6511,8382,1102,3664908331,1621,4761,7762,0632,3382,600608789-4,2381,4171,7780
       Long-term Liabilities Other 
0
32,149
32,222
32,174
33,800
26,941
26,992
27,044
27,626
21,829
21,833
21,835
25,942
18,850
18,845
18,844
21,175
11,905
11,922
11,944
13,942
13,94211,94411,92211,90521,17518,84418,84518,85025,94221,83521,83321,82927,62627,04426,99226,94133,80032,17432,22232,1490
> Total Stockholder Equity
1,563,485
1,555,438
1,519,053
1,496,709
1,408,226
1,242,349
1,369,513
1,390,419
1,425,961
1,394,982
1,402,381
1,382,178
1,378,866
1,375,788
1,423,010
1,382,860
1,410,827
1,503,274
1,483,634
1,467,140
1,468,770
1,468,7701,467,1401,483,6341,503,2741,410,8271,382,8601,423,0101,375,7881,378,8661,382,1781,402,3811,394,9821,425,9611,390,4191,369,5131,242,3491,408,2261,496,7091,519,0531,555,4381,563,485
   Common Stock
1,008,060
1,008,060
1,008,060
1,058,149
1,058,149
1,058,149
1,058,149
1,078,886
1,078,886
1,078,886
1,078,886
1,100,038
1,100,038
1,093,758
1,093,758
1,093,758
0
1,093,758
1,093,758
0
0
001,093,7581,093,75801,093,7581,093,7581,093,7581,100,0381,100,0381,078,8861,078,8861,078,8861,078,8861,058,1491,058,1491,058,1491,058,1491,008,0601,008,0601,008,060
   Retained Earnings 
196,090
191,244
141,620
145,520
187,886
161,324
165,900
185,799
185,137
152,485
155,061
153,527
167,974
205,044
208,247
215,267
105,649
66,845
176,979
29,673
13,498
13,49829,673176,97966,845105,649215,267208,247205,044167,974153,527155,061152,485185,137185,799165,900161,324187,886145,520141,620191,244196,090
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
175,372
131,234
138,687
62,354
17,232
-122,083
505
-19,980
16,224
17,897
22,535
-17,284
-35,043
-82,943
-38,924
-86,094
0
35,633
2,341
0
0
002,34135,6330-86,094-38,924-82,943-35,043-17,28422,53517,89716,224-19,980505-122,08317,23262,354138,687131,234175,372



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue528,512
Cost of Revenue-317,596
Gross Profit210,916210,916
 
Operating Income (+$)
Gross Profit210,916
Operating Expense-501,519
Operating Income26,993-290,603
 
Operating Expense (+$)
Research Development73,613
Selling General Administrative110,310
Selling And Marketing Expenses0
Operating Expense501,519183,923
 
Net Interest Income (+$)
Interest Income5,018
Interest Expense-267
Other Finance Cost-0
Net Interest Income4,751
 
Pretax Income (+$)
Operating Income26,993
Net Interest Income4,751
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,82526,993
EBIT - interestExpense = -267
29,334
29,601
Interest Expense267
Earnings Before Interest and Taxes (EBIT)031,092
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax30,825
Tax Provision-1,491
Net Income From Continuing Ops29,33429,334
Net Income29,334
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,751
 

Technical Analysis of Genovate Biotechnology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genovate Biotechnology Co Ltd. The general trend of Genovate Biotechnology Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genovate Biotechnology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genovate Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 24.30 < 24.70 < 24.70.

The bearish price targets are: 23.60 > 21.08.

Tweet this
Genovate Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genovate Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genovate Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genovate Biotechnology Co Ltd. The current macd is -0.29827364.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genovate Biotechnology Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genovate Biotechnology Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genovate Biotechnology Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genovate Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGenovate Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genovate Biotechnology Co Ltd. The current adx is 31.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Genovate Biotechnology Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Genovate Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genovate Biotechnology Co Ltd. The current sar is 24.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Genovate Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genovate Biotechnology Co Ltd. The current rsi is 38.38. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Genovate Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartGenovate Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genovate Biotechnology Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genovate Biotechnology Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genovate Biotechnology Co Ltd Daily Stochastic Oscillator ChartGenovate Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genovate Biotechnology Co Ltd. The current cci is -76.56815064.

Genovate Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartGenovate Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genovate Biotechnology Co Ltd. The current cmo is -23.79127528.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genovate Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGenovate Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genovate Biotechnology Co Ltd. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Genovate Biotechnology Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Genovate Biotechnology Co Ltd Daily Williams %R ChartGenovate Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genovate Biotechnology Co Ltd.

Genovate Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genovate Biotechnology Co Ltd. The current atr is 0.33613808.

Genovate Biotechnology Co Ltd Daily Average True Range (ATR) ChartGenovate Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genovate Biotechnology Co Ltd. The current obv is 211,606,728.

Genovate Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartGenovate Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genovate Biotechnology Co Ltd. The current mfi is 40.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Genovate Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartGenovate Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genovate Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Genovate Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genovate Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.385
Ma 20Greater thanMa 5024.593
Ma 50Greater thanMa 10025.048
Ma 100Greater thanMa 20025.745
OpenGreater thanClose24.300
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genovate Biotechnology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Genovate Biotechnology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genovate Biotechnology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genovate Biotechnology Co Ltd

I send you an email if I find something interesting about Genovate Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Genovate Biotechnology Co Ltd.

Receive notifications about Genovate Biotechnology Co Ltd in your mailbox!